Initial ex vivo analyses of the bone marrow revealed a 48% higher frequency of IL-17-producing T cells in acute lymphoblastic leukemia patients at the moment of diagnosis compared to the healthy control group (1.28% versus 0.86%; p = 0.0155). Here, IL17A is linked to acute lymphoblastic leukemia.